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Abstract
Carcinoma-associated fibroblasts (CAFs) are abundant stromal cells in tumor microenvironment that are critically
involved in cancer progression. Contrasting reports have shown that CAFs can have either pro- or antitumorigenic
roles, indicating that CAFs are functionally heterogeneous. Therefore, to precisely target the cancer-promoting
CAF subsets, it is necessary to identify specific markers to define these subpopulations and understand their
functions. We characterized two CAFs subsets from 28 non–small cell lung cancer (NSCLC) patient tumors that
were scored and classified based on desmoplasia [mainly characterized by proliferating CAFs; high desmoplastic
CAFs (HD-CAF; n = 15) and low desmoplastic CAFs (LD-CAF; n = 13)], which is an independent prognostic factor.
Here, for the first time, we demonstrate that HD-CAFs and LD-CAFs show different tumor-promoting abilities. HD-
CAFs showed higher rate of collagen matrix remodeling, invasion, and tumor growth compared to LD-CAFs.
Transcriptomic analysis identified 13 genes that were differentially significant (fold ≥1.5; adjusted P value b .1)
between HD-CAFs and LD-CAFs. The top upregulated differentially expressed gene, ST8SIA2 (11.3 fold; adjusted P
value = .02), enhanced NSCLC tumor cell invasion in 3D culture compared to control when it was overexpressed
in CAFs, suggesting an important role of ST8SIA2 in cancer cell invasion. We confirmed the protumorigenic role of
ST8SIA2, showing that ST8SIA2 was significantly associated with the risk of relapse in three independent NSCLC
clinical datasets. In summary, our studies show that functional heterogeneity in CAF plays key role in promoting
cancer cell invasion in NSCLC.
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Introduction
Tumor stroma is no longer seen solely as physical support for mutated
epithelial cells but as an important modulator and even a driver of
tumorigenicity in nonsmall cell lung cancer (NSCLC) [1,2]. One of
the most consistent histological features of cancer cell invasion is the
changes in tumor stroma recognized as desmoplasia. Desmoplasia is
characterized by the activation of stromal fibroblasts into
carcinoma-associated fibroblasts (CAFs), increased matrix protein
disposition, new blood vessel formation, and immune cell infiltration.
Desmoplasia is associated with tumor aggressiveness, which includes
tumor cell growth, invasion, and metastases, suggesting that specific
cellular or ECM components of desmoplasia promote tumor
progression and metastasis [35]. Within the tumor stroma milieu,
CAFs are the major stromal components in many types of
malignancies that play a crucial role in tumor development [611]
and are potential therapeutic targets for cancer [6]. However, recent
studies suggest that CAFs are heterogeneous and contain different
subpopulations with distinct phenotypes and functions, which hinder
their application in diagnosis and targeted therapy [12,13]. Although
significant prognostic impacts of CAFs have been studied in various
tumors, including breast and lung cancers, whether CAFs are
associated with good or poor prognosis is contradictory in different
studies [14]. These studies present encouraging proof-of-concept
findings that CAFs could be exploited for prognostication; however,
they also highlight the difficulties to conclusively define an activated
stroma and to identify the individual factors involved in clinically
relevant tumor-stroma interactions. Basically, although it is generally
thought that CAFs promote tumor progression, targeting alpha
smooth muscle actin (α-SMA)expressing CAFs leads to disease
exacerbation in cohort of pancreatic cancer patients [15] and in a
mouse model of pancreatic cancer [16,17], suggesting that different
fibroblast subsets may exert opposite functions in cancer progression.
For example, in oral squamous cell carcinoma, two CAF subtypes
have been identified that have differential tumor-promoting
capability [11]. Therefore, to precisely target the cancer-promoting
CAF subsets, it is necessary to identify specific markers to define these
subpopulations and understand their functions.
Here we studied the biological and molecular basis of CAF
heterogeneity in desmoplasia-based tumor aggressiveness. Our data
demonstrated that CAFs isolated from high and lowCAF density
tumors displayed different tumor-promoting abilities, independent of
their cell number, indicating that these functional differences
contribute to the aggressiveness of the tumor. In summary, we
provide further insights into the biological and molecular basis of
CAF heterogeneity.
Materials and Methods
Supplementary Figure S1 summarizes all the methods and sample
number used in each assay and is described in Supplementary data.
For the rest of Materials and Methods, please refer to Supplementary
data.
Histological Assessment of Desmoplasia in NSCLC Tumors
Hematoxylin and eosin (H&E) slides were prepared from
formalin-fixed, paraffin-embedded tissue of surgically resected lung
tumors. Tumors were classified into high desmoplasia (HD) or low
desmoplasia (LD) according to histological features, mainly the
percentage of desmoplastic areas (DAs) in the tumor stroma, as
assessed by three trained pathologists (S. S., T. W., M. F. S. N.). The
DA was defined by high density of proliferating fibroblasts possessing
enlarged nuclei greater than the size of a lymphocyte. The estimated
DA was used as a proxy for characterizing HD or LD: if the DA
occupied 50% or more of the tumor stroma, the tumor was
considered HD. Conversely, those with b50% DA were classified as
LD. These criteria were used to assess desmoplasia in 165 tumors
(initially based on 169 tumors; 4 were excluded due to lack of patient
information on recurrence) from UHN non-small cell lung cancer
(NSCLC) patients on whom we have previously conducted
microarray gene expression profiling [18], as well as 28 NSCLC
tumor samples and their corresponding normal lung prior to
extracting and culturing primary CAFs (CAF cohort) and normal
fibroblast (NF) cells, respectively. Desmoplasia scoring on 28 tumors
(primary human lung cancer) that were used to establish CAF and
their corresponding NF cultured cells were further validated in the
corresponding surgical slides. Desmoplasia was tested utilizing the
percent stroma in the tissue as the weight in the analysis. Initial
independent scores from two pathologists resulted in 77% and 86%
agreement in the UHN cohort (n = 165) and the CAF cohort (n =
28), respectively; the discrepant cases were discussed, and a
desmoplasia classification was achieved.
Isolation and Primary Culture of Fibroblasts
The study was conducted using a protocol approved by the
Institutional Research Ethics Board. The tumor and matched normal
lung tissue (at least 5 cm away from tumor) from 28 resected NSCLC
specimens were harvested within 30 minutes after surgical resection,
and they were used to establish cultured CAF and corresponding NF
cell lines, respectively, as previously described [1]. Sampled tissues
were placed in Dulbecco's modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and antibiotics
(Invitrogen, Mississauga, ON) for immediate transportation on ice to
the laboratory. Tissues were minced into small pieces and digested for
1 hour at 37°C in DMEM containing 10% FBS and 0.4 mg/ml
collagenase type I (Worthington Biochemical, Lakewood, NJ). The
cell suspension was centrifuged at 180×g for 5 minutes, and the pellet
was resuspended in the fresh DMEM containing 10% FBS and plated
onto 100-mm tissue culture plates. Based on this protocol, we were
able to establish 28 CAF and their corresponding NF primary culture
cells. All CAF primary cultured cells were used at early passage. We
maintained all CAF/NF cell lines at early passage (passage 2-5).
Tissue sections from the 28 CAF specimens were formalin-fixed
and paraffin-embedded for histologic evaluation of desmoplasia.
H&E staining of paraffin-embedded NSCLC tumor tissues was
scanned using ScanScope AT2 (Leica Biosystems, Buffalo Groove,
IL) at 20× (~0.5 μm/pixel).
Collagen Gel Contraction
This assay was performed as previously described [19]. Contraction
of collagen was performed in 96-well plate. The plates were coated
with sterile filtered 2% BSA in PBS (225 μl/well), incubated at 37°C
overnight, and then washed three times with sterile PBS before use
(250 μl/well). Fibroblasts were trypsinized, washed three times with
serum free DMEM, and diluted to the cell suspension of 1 × 106
cells/ml. The cell suspension was mixed on ice with collagen solution
[5 parts 2× DMEM, 1 part 0.2 M Hepes, and 4 parts collagen I
(Advanced Biomatrix, San Diego, CA; 3.1 mg/ml)] at a ratio of 1:9,
yielding a final concentration of 1 × 105 cells/ml and 1.2 mg/ml of
collagen. A total of 100 μl collagen/cell suspension was added to each
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well without introducing air bubbles. The plate was immediately
incubated at 37°C to allow gels to form. After 1 hour, 100 μl
DMEM was added to each well to float the gel. The plate was then
incubated at 37°C for the desired time periods (after 2, 5, 8, and
24 hours). The contraction process was measured by analyzing the
diameters under an inverted microscope with an ocular micrometer.
Twenty-six CAFs and 23 NFs with multiple replicates were evaluated
in gel assessed by the size of the diameter measured at baseline and
then at 2, 5, 8, and 24 hours. One sample had 6 replicates, 4 samples
had 7 replicates, 7 samples had 8 replicates, 28 samples had 9
replicates, and 9 samples had 12 replicates.
Invasion and Migration Assay
Tumor cell invasion was assessed in vitro by the reconstituted
basement membrane (Matrigel) invasion assay, which was performed
using 8-μm polycarbonate filters coated with reconstituted basement
membrane (Matrigel; BD Biosciences) as previously described [1].
Prior to coating, Matrigel was diluted with cold distilled water, and
14 μg in 60 μl was added to each filter. The coated filters were dried
overnight and equilibrated with serum-free RPMI for 2 hours. The
medium was then removed, and the filters were placed in 24-well
plates. To measure the migratory ability of A549 tumor cells, we used
noncoated filters. Following this, to each filter, 5 × 104 A549 NSCLC
tumor cells were added in 100 μl of RPMI containing 0.2% BSA for
a 48-hour incubation at 37°C in a humidified 5% CO2 incubator.
For co-culture assays, 5 × 104 HD-CAFs (n = 2) and LD-CAFs (n =
2) and their corresponding NFs were added to the lower chamber. To
study the invasion and migratory ability of A549 tumor cells in
co-culture with extreme desmoplastic CAFs, we used HDEX-CAFs
(n = 3) or LDEX-CAFs (n = 3). At the end of the incubation period,
the cells on the upper surface of the filters were removed with a cotton
swab, and the filters were fixed in 0.1% glutaraldehyde and stained
with 0.2% crystal violet. The number of cells that migrated to the
lower side of the filter was counted with a Nikon Upright microscope
(OPTIPHOT; ×100) using the Image Pro program. The whole area
was counted per filter. The assay was done in triplicates.
In Vivo Tumorigenicity Assay
Severe combined immune-deficient (SCID) mice were bred on-site
at the Princess Margaret Cancer Centre animal facility. All
manipulations were done under sterile conditions in a laminar flow
hood in accordance with protocols approved by the Princess Margaret
Cancer Centre Animal Care Committee. The tumorigenicity of cell
lines was tested in 6-week-old male SCID mice by subcutaneous
implantation of 2 × 106 A549 cells (nonsmall cell lung
adenocarcinoma cell line purchased from the American Type Culture
Collection and cultured in RPMI 1640 medium supplemented by
10% FBS) with and without 2 × 106 HD-CAFs or LD-CAFs into the
abdominal flanks of the mice. In order to explore the difference of
tumor-promoting potentials between HD-CAFs and LD-CAFs, four
HD-CAFs and four LD-CAFs were selected. The corresponding NFs
and A549 alone was used as controls. Five mice were used for each
experimental group. Tumor volume was calculated as (length ×
width2) × pi/6.
3D Matrix Invasion Assay
A549 tumor cell line was stably transfected with a retrovirus
harboring dsred tag (A549dsred) and cultured as homospheroid and as
heterospheroid with HDEX-CAFs (n = 3) or LDEX-CAFs (n = 3)
[20] using the Nunclon Sphera plate (VWR, Mississauga, ON).
Either tumor cells or fibroblasts were diluted to 1 × 106 cells/ml, and
a ratio of 1:4 (tumor cells:fibroblasts) was used for making
heterospheroids. Briefly, confluent monolayers were trypsinized,
resuspended as single cells in RPMI +10% FBS (A549dsred cells) or
DMEM +10% FBS, and plated in drop of 40 μl per well of 96-well
Sphera plate. Cells began to form spheroids after 1 day [20]. On day
2, the spheroids were flushed in collagen type I gel and were visualized
under Zeiss LSM700 confocal fluorescent microscope (Zeiss,
Toronto, ON) using 5 × 0.25 NA objective at day 2 postembedding.
The 3D matrix invasion areas were analyzed using texture analysis
available as a plugin for the freeware Image J analysis software (http://
imagej.nih.gov/ij/index.html) to evaluate the pixels in different
directions around the spheroid, which is a measure of invading area.
RNA Extraction from Collagen Gel-Embedded CAFs
Cells (1 × 105) at passage 2 were seeded in 500 μl 3-D collagen
type I gel matrix [5 parts 2× DMEM, 1 part 0.2 MHepes, and 4 parts
collagen type I (Advanced Biomatrix, San Diego, CA)] at a
concentration of 3.1 mg/ml in a 24-well plate. After 24 hours, 1
ml of Trizol (Invitrogen, Mississauga, ON) was added to each well,
and the gel was homogenized with a 1000-μl pipette.
Reverse-Transcriptase/Quantitative Polymerase Chain Reaction
(RT-qPCR) Expression Profiling
Total RNA (2 μg) was reverse-transcribed using Superscript II
reverse transcriptase (Invitrogen, Mississauga, ON). A 10-ng
equivalent of complementary DNA was used for each qPCR assay,
performed with the Stratagene Mx3000p Sequence Detection System
using SYBR green 2× master mix (Stratagene, La Jolla, CA).
Intron-spanning primers were designed using the Primer Express
software (Perkin-Elmer Applied Biosystems, Foster City, CA). For
validation of microarray expression, primers were designed based
microarray probe sets using primer blast. Absolute mRNA expression
and calculation for copy number gene expression were based on
standard curve for each gene using control human normal lung
genomic DNA. Primer sequences for ST8SIA2 gene expression were
designed based on Affymetrix-specific probe set: (forward) 5-CCAG-
TACAGGAGTATGCCCG and (reverse) 5-TGGCATTGAC-
CAAGTCCTCA. The values were normalized using housekeeping
genes (RPS13 and B2M when indicated).
Microarray Gene Expression Profiling
The gene expression was obtained in extreme desmoplastic CAFs
(four HDEX-CAFs and four LDEX-CAFs; one HDEX-CAF went to
senescence and was excluded from gene expression analysis). Early
passage (passage 2) cultures of the 7 CAFs were embedded in collagen
gel for 24 hours, and total RNA was isolated as described previously
[21]. The gene expression microarray profiling was performed by the
Princess Margaret Genomics Centre (https://www.pmgenomics.ca/
pmgenomics/) using the Illumina Human HT-12v4 DASL micro-
array platform. The raw data from BeadChips (seven samples passed
Illumina sample-dependent and -independent quality controls
matrices) were preprocessed using BeadArray specific method (R
package lumi v3.) for Illumina microarray [22]. The signal intensities
were log2 transformed, background corrected, and normalized using
robust spline normalized method. The signals were then filtered using
the probe signal detection threshold (P b .05). Expression values
were summarized at the gene-core/whole-transcript level based on
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HT12v4 annotation library. Preprocessed data are available through
the Gene Expression Omnibus database (https://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE116679).
Differentially expressed genes between HD-CAFs and LD-CAFs
were identified by robust linear model analysis (fold change ≥1.5;
adjusted P value b .1, R package).
Western Blot Analysis
The experimental procedure is described in Supplementary data.
Stable Transfection of Polysialyltransferase (ST8SIA2) Construct
into CAFs Primary Cultured Cells
Lentiviral vector carrying ST8SIAII (pLenti-GIII-CMV-ST8SIA2)
for overexpressing ST8SIA2 in HD-CAF and the control vector
(pLenti-GIII-CMV-GFP) were purchased from ABM (Richmond,
BC). ORF expression clone for ST8SIAII (EX-U0376-Lv122) for
overexpressing ST8SIAII in LD-CAF and empty control vector
(pReceiver-Lv122 (EX-NEG-lV122)) were purchased from Gene-
Copoeia (Rockville, MD). Lentiviruses were prepared as described [1]
by transfecting three plasmids into 293T cells: 1) pMDLg/pRRE, the
vesicular stomatitis virus (VSV-G) envelope plasmid pCMV-VSG; 2)
the rev-expressing plasmid pRSV-Rev; and 3) one of either of the gene
transfer vector pLenti-GIII-CMV-ST8SIA2 or the empty control
pLenti-GIII-CMV-GFP vector. Stocks were stored frozen at −80°C.
Early passage cultures of HDEX-CAFs were infected with the
ST8SIA2 lentivirus or empty control lentivirus.
Stable knockdown of ST8SIAII gene expression in HD-CAF was
established using lentiviral- shRNA vector (plentiLox; PLL 3.7.
ST8SIA2 shRNA). As control, we used lentiviral- shRNA vector
expressing GFP (plentiLox; PLL 3.7.GFP shRNA). The stably
transfected cells were selected using 1 μg/ml puromycin.
Statistical Analysis
Differences in tumor growth rates of xenografts between
HD-CAFs and LD-CAFs and NFs were tested using linear
mixed-effects model. To stabilize the residuals, a square root
transformation was applied to the tumor volume. The differences
in migration, invasion, and mRNA expression between HD and LD
were tested by Mann-Whitney test. The Wilcoxon signed rank test
was utilized for the comparison between CAFs and NFs for their gel
contraction activity. For the association between the desmoplasia and
the relapse rate (RR), the time to event was calculated as the duration
between surgery and either relapse or death or last-follow-up. The
occurrence of relapse was the event for RR. The deaths in the absence
of relapses were considered competing risk. The probability of relapse
was calculated with the competing risks specific techniques (cmprsk
package in R 3.2.2), i.e., the estimation of the probability of relapse
was based on the cumulative incidence function, and the adjusted
effect of desmoplasia on relapse was tested utilizing the Fine and Gray
model. Since in the UHN cohort the desmoplasia was assessed in the
tumor and not necessarily in only stroma, the analysis was weighted
for the amount of stroma in the tumor tissue for each patient.
Results
Clinical Impact of Desmoplasia on NSCLC Prognosis
We first investigated whether high CAF content was indeed
associated with more aggressive tumors. Tumors were classified into
HD or LD according to histological features, mainly the percentage of
DAs in the tumor stroma. The DA was defined by high proliferation
of fibroblasts. The estimated DA was used as a proxy for
characterizing HD or LD (Figure 1). Two pathologists assessed the
degree of desmoplasia in representative tumor sections of 165
NSCLC patients (UHN cohort) who had undergone curative
resection. Using their consensus scores, 61 tumors (37%) were
classified as HD and 104 (63%) as LD (Figure 2, A and B;
Supplementary Table S1). Desmoplasia was associated with the risk
for relapse in this patient cohort. The patients with HD tumors had
significantly higher RR than those with LD tumors (HR = 2.45; P
value = .011) (Figure 2C). The prognostic impact of desmoplasia
remained significant when the model was adjusted for age, sex, stage,
and tumor histology (HR = 2.47, P = .027) (Table 1). This
association was stronger among adenocarcinoma patients. The
patients with HD had poor outcome in comparison to the patients
with LD (HR = 4.01, P = .00064, Figure 2D). The desmoplasia
characteristic remained significant when the effect was adjusted for
age, sex, and stage (HR = 3.69, P = .004) (Table 1).
To determine whether CAF density or CAF functional heteroge-
neity contributes to the aggressiveness of the tumor, we isolated CAFs
from 28 NSCLC resected tumors. Using the same predefined criteria,
desmoplasia was assessed in 28 NSCLC tumor samples prior to
extracting and culturing primary CAF cells (CAF cohort) (Supple-
mentary Table S2). Most tumors (23/28; 82.14%) were diagnosed as
adenocarcinoma. Fifteen samples were classified as HD tumors and
13 as LD tumors. To avoid heterogeneity issues associated with
sampling, the histologic review and DA scores on these tumors (26/
28) were validated in multiple tumor regions from corresponding
surgical pathology specimens except one tumor, which was classified
as LD in the surgical slide and as HD in CAF cohort (Supplementary
Table S3).
To confirm the absence of chromosomal variations in primary
fibroblasts cell cultures (CAFS and their matched NFs), we performed
Shallow WGS-CNV sequencing to analyze copy number variation.
We showed that CAF and corresponding NF primary cell cultures are
diploid compared to the three randomly selected established human
tumor cell lines (Supplementary Figure S2).
CAF-Specific Markers in HD- and LD-CAFs
Since in our previous studies α-SMA and integrin α11 were both
recognized as important markers of CAFs in lung cancer [1,21], we
asked whether HD- and LD-CAFs could be characterized depending
on these markers. These two markers were assessed by Western blot
analysis on the 23 cultured CAF and NF primary cultured cells. The
expression of integrin α11 and α-SMA was significantly higher in
CAF compared to their corresponding NF primary cultured cells
(Supplementary Figure S3, A and B; Supplementary Table S5). We
also observed a significant correlation between α-SMA and integrin
α11 protein levels in CAFs (r = 0.63; P = .0013) (Supplementary
Figure S3C; Supplementary Table S4) as well as in NFs (r = 0.61;
P = .0019) (Supplementary Figure S3D; Supplementary Table S4).
Although we observed a significant difference between CAFs and NFs
at the protein levels for both integrin α11 and α-SMA (P = .0002
and P = .0018, respectively), the differences between HD-CAFs and
LD-CAFs were not statistically significant (Supplementary Table S5).
Using RT-qPCR, we further evaluated in 26 desmoplastic CAF
primary cultured cells the expression of 11 genes that made up our
previously published CAF prognostic gene signature [1] (for primers
list, please refer to Supplementary Table S6). The mRNA expressions
of 6 out of the 11 genes (B3GALT2, OXTR, PDE3B, CLU,
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COL14A1, and GAL) were significantly different between CAFs and
NFs, validating the findings of our earlier study [1] (Supplementary
Table S7). These results remained significant after a Bonferroni
adjustment for multiple testing was applied. Of these six genes, two
were upregulated in CAFs (B3GALT2 and OXTR) and four were
downregulated in CAFs (PDE3B, CLU, COL14A1, and GAL)
(Supplementary Table S7). However, none of the 11 prognostic genes
showed statistical significant difference between HD-CAFs and
LD-CAFs (Supplementary Table S7).
HD-CAFs Enhance Collagen Matrix Remodeling and Tumor-
igenicity of NSCLC cells
We aimed to determine whether the desmoplasia-associated poor
prognosis was due to CAF density only or to differences in
desmoplastic CAF functions. We first evaluated the ability of primary
cultured CAFs to remodel collagen matrix (in vitro recognized as
collagen gel contraction), which has been shown to affect tumor
invasion and growth [2]. We showed that HD-CAFs had significantly
higher collagen gel contraction activity compared to LD-CAFs
(Figure 3A, Supplementary Table S8). Also, we showed that
LD-CAFs behaved the same as NFs, and both were different from
HD-CAFs. We then measured ability of desmoplastic CAFs in
promoting tumor cell invasion. We selected two HD-CAF and two
LD-CAF primary cultured cells and their matching NFs based on
their level of collagen gel contraction. Using in vitro Transwell
Matrigel invasion assay, we observed increased invasion of A549
tumor cells into Matrigel in co-culture with HD-CAFs but not with
LD-CAFs or A549 tumor cells alone (Figure 3B and Supplementary
Table S9). Furthermore, in vitro co-culture migration assay showed
increased migration of A549 tumor cells in co-culture with HD-CAFs
but not with LD-CAFs or alone (Figure 3B and Supplementary Table
S9). To confirm aggressiveness of high desmoplastic CAFs, we did an
in vivo tumor growth assay. In addition to selected CAFs used in in
vitro invasion and migration assay, we included two HD-CAF and
two LD-CAF primary cultured cells and their matching NFs based on
collagen remodeling. Both HD- and LD-CAF cells were separately
co-injected subcutaneously with A549 tumor cells into SCID mice.
The tumor growth rate for all in vivo tumor-promoting curves of
eight pairs of CAFs and NFs co-injected with A549 tumor cells
including A549 tumor cell alone as control was analyzed using the
mixed-effect model. The tumor growth rate in the HD-CAFs/A549
was significantly higher than in LD-CAFs/A549 and NFs/A549
(P b .0001; Supplementary Table S10), but there was no statistical
difference between LD-CAFs/A549 versus NF/A549 (P = .66;
Figure 3C). We did not observe any tumor growth when we injected
HD-CAFs, LD-CAFs, or NFs alone. We observed the slowest tumor
growth rate in tumor from injecting A549 tumor cells alone. This
implies that the increased tumor growth rate observed in HD-CAFs/
Figure 1. Definition of desmoplasia. H&E slides were prepared from formalin-fixed, paraffin-embedded tissue of surgically resected lung
tumors. Each tumor samplewas graded asHDor LDbased on the percentage ofDAs in total tumor stroma, as assessed by twopathologists.
The high–desmoplasia area (HDA) stroma is defined by the following characteristics: a high density of fibroblasts with minimal intervening
mature collagen, and fibroblasts possessing enlarged nuclei greater than the size of a lymphocyte. If the stromal HDAoccupies 50%ormore
of the tumor stromal area, the tumor is considered to have HD. Conversely, those with b50% HDA are classified as LD.
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A549, LD-CAFs/A549, and NFs/A549 was due to the promoting
ability of fibroblasts. These data indicated that high level of
desmoplasia is associated with tumor aggressiveness, independent of
the CAF number, thus suggesting that the aggressiveness of the tumor
depends more on CAF function rather than CAF density.
HDEX-CAFs Enhance Invasion of NSCLC Tumor Cells
We then aimed to understand the molecular mechanisms of high
desmoplastic CAFs in tumor aggressiveness. We focused on collagen
matrix remodeling where differences in gel contraction between HD-
and LD-CAFs indicated that they are behaving in a functionally
different manner. Therefore, HD-CAFs and LD-CAFs were clustered
based on their correlation between collagen matrix remodeling
activity (collagen gel contraction) and desmoplasia (Supplementary
Figure S4). We noticed an overlap of HD-CAFs and LD-CAFs when
the DA score ranged from 20% to 60%. Therefore, we selected three
extreme HD-CAFs (HDEX-CAFs; desmoplasia N60% and collagen
gel diameter b median) and four extreme LD-CAFs (LDEX-CAFs;
desmoplasia b20% and collagen gel diameter N median) to better
define CAF subgroups for functional analysis. In vitro 3D collagen
matrix invasion assay showed increased invasion of A549dsRed tumor
cells into collagen type I in heterospheroid culture with HDEX-CAFs
but not with LDEX-CAFs or as monospheroid of A549dsred tumor
cells isolated (Figure 3, D and E and Supplementary Table S11).
Using in vitro co-culture Matrigel invasion assay, we observed
increased invasion of A549 tumor cells into Matrigel in co-culture
with HDEX-CAFs but not with LDEX-CAFs or A549 tumor cells
alone (Figure 3F and Supplementary Table S12). Furthermore, in
vitro co-culture migration assay showed increased migration of A549
tumor cells in co-culture with HDEX-CAFs but not with LD-
EX-CAFs or alone (Figure 3F and Supplementary Table S12).
Gene-Expression Profile of HD-CAFs in NSCLC
To evaluate genes that are involved in tumor aggressiveness of high
desmoplastic CAFs, differential gene expression analysis was
performed. A total of 13 differentially expressed genes (nine
upregulated and four downregulated) were identified (fold change N
1.5; adjusted P value b .1) between HDEX-CAFs and LDEX-CAFs
(accession no. GSE116679) (Figure 4A; Supplementary Table S13).
The genes with fold change expression ≥2 and ≤−2 were selected for
validation (Figure 4B). Using RT-qPCR, we validated four
Figure 2. The association between desmoplasia and the RR was tested for 165 patients. (A and B) The criteria for desmoplasia as
described in Figure 1 were used to assess desmoplasia in 165 tumors from UHN NSCLC patients. (C) The RR was estimated using the
cumulative incidence function, and the comparison between 165 HD and LD tumors was performed using Wald test within the Fine and
Gray model. (D) The association between desmoplasia and the RR within adenocarcinoma subgroup was tested for 116 patients. The RR
was estimated using the cumulative incidence function, and the comparison between HD and LD tumors was performed usingWald test
within the Fine and Gray model.
Table 1. The Effect of Desmoplasia on Clinical Outcome
UHN (n = 165) UHN-Adenocarcinoma
(n = 116)
HR 95% CI P Value HR 95% CI P Value
Age (≥65 vs. b65) 1.16 0.48-2.77 .74 1.01 0.34-3.03 .98
Sex (M vs. F) 1.58 0.74-3.38 .24 1.11 0.45-2.74 .83
Stage (II vs. I) 1.54 0.72-3.29 .27 1.39 0.53-3.61 .5
Histology (Ade vs. other) 1.59 0.69-3.69 .28
Desmoplasia (HD vs. LD) 2.47 1.11-5.53 .027 3.69 1.52-8.98 .004
RR was adjusted for clinical factors in the UHN cohort and adenocarcinoma patient subgroup
when the model was weighted for the amount of stroma. The Fine and Gray model was utilized.
Ade, adenocarcinoma.
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significantly upregulated genes (ST8SIA2, WNT7B, SLITRK6, and
IGFL3) (Figure 4C; for primers list, please refer to Supplementary
Table S14). RT-qPCR failed to validate the gene expression ofHEPH
and SCML1 (Figure 4C and Supplementary Table S15).
To be consistent with our selection of extreme desmoplasia cases in
CAF cohort, we subgrouped 165 NSCLC patients in UHN clinical
cohort to extreme desmoplasia cases (HDEX-UHN cohort; desmo-
plasia N60% and LDEX-UHN cohort; desmoplasia b20%).
RT-qPCR analysis using Affymetrix probe set-specific primers
showed that the most top upregulated differentially expressed gene,
ST8SIA2, has significant increase in copy number gene expression
(P value = .026) in HDEX-UHN cohort compared to LDEX-UHN
cohort (Figure 4D and Supplementary Table S16).
ST8SIA2 Enhances the Invasion of NSCLC Tumor Cells
To investigate the function of ST8SIA2 in tumor aggressiveness,
we first confirmed ST8SIA2 protein expression in three HDEX-CAFs
compared to three LDEX-CAFs (Figure 5, A and B, Supplementary
Table S17, P = 7.396e-07). We transfected two different ST8SIA2
shRNAs in HDEX-CAF (shST8SIA2#1 and shST8SIA2#2), display-
ing 73% and 33% of ST8SIA2 expression inhibition, respectively
(Figure 5C and Supplementary Table S18). Knockdown of 70% of
Figure 3. Desmoplasia-related CAF heterogeneity influences collagen matrix remodeling and tumor cell growth and dissemination. (A)
The collagen gel contraction estimates at each time point for LD-CAFs, HD-CAFs, and their corresponding NFs. The lines represent the
averages of the diameters per group and at each specific time point. The comparisons between groups at each time point were
performed utilizing the Wilcoxon signed rank test. (B) In vitro Transwell assay measuring the invasion and migration ability of A549 tumor
cells in co-culture with HD-CAFs or LD-CAFs. Quantification has been performed using the Image Pro program. Statistic tables for each
data are provided in Supplementary data. (C) HD-CAFs, LD-CAFs, and NFs were individually mixed with A549 tumor cells and were
co-injected subcutaneously in SCID mice. The graph shows the predicted tumor growth across the groups (81 mice) and analyzed based
on mixed-effect model. The significance is analyzed using the mixed-effect model. (D) Heterospheroids of HDEX-CAFs + A549dsred or
LDEX-CAFs + A549dsred as well as monospheroid of A549dsred cells were embedded in collagen gel, and the invasion into the collagen
type I gel were visualized for 2 days using confocal microscopy. Scale bars: 200 μm. (E) Quantification of the A549dsred tumor cell
invading area measured by image J. (F) In vitro Transwell assay measuring the invasion and (G) migration ability of A549 tumor cells
co-culture with HDEX-CAFs or LDEX-CAFs. Quantification has been performed using the Image Pro program. Statistical analysis for each
data is provided in Supplementary data (Supplementary Table S8-12).
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Figure 4.Differential gene expressions in HDEX-CAFs versus LDEX-CAFs. (A) Heat map of 13 differential gene expressions between HDEX-CAFs and LDEX-CAFs. Pearson's correlation
coefficients between all samples were calculated based on 13 differential gene expressions between HDEX-CAFs and LDEX-CAFs. Agglomerative hierarchical clustering was
performed using these correlation coefficients as the distance metric and complete linkage. Rows correspond to individual genes, and columns correspond to individual samples.
(B) Five upregulated (fold change ≥ 2; adjusted P value b .1) and one downregulated (fold change ≤ −2; adjusted P value b .1) expression genes in HDEX-CAFs versus LDEX-CAFs
were selected for RT-qPCR analysis. (C) Differential gene expressions in Microarray analysis were validated by absolute RT-qPCR using mRNA from three HDEX-CAF and four
LDEX-CAF primary cultured cells. (D) Using RT-qPCR, the difference for the top upregulated differential gene expression (ST8SIA2) in extreme desmoplastic tumors in UHN clinical
cohort (HDEX-UHN cohort and LDEX-UHN cohort) was calculated, and statistic was performed using Mann-Whitney test. The values were normalized using the housekeeping gene
RPS13. Absolute mRNA expression was based on standard curve for each gene using control normal human lung genomic DNA. Statistical analysis for each data is provided in
Supplementary data (Supplementary Table S15 and 16).
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ST8SIA2 gene expression in HDEX-CAF shST8SIA2#1 resulted in a
significant inhibition of A549dsred tumor cells invasion into collagen
type I in heterospheroid cultures (Figure 5D and Supplementary
Table S19, P = .0022). Inhibition of ST8SIA2 gene expression by
30% in HDEX-CAF shST8SIA2#2 also showed a decrease in A549dsred
tumor cells invasion that however was not significant. In parallel,
stable overexpression of ST8SIA2 in HDEX-CAFST8SIA2 (Figure 5E)
showed a significant increase in invasion of A549dsred tumor cells into
3D collagen type I matrix compared to corresponding control GFP
transfected HDEX-CAF (HDEX-CAFGFP) (Figure 5F and Supple-
mentary Table S19, P = .0042). We then overexpressed ST8SIA2 in
LDEX-CAF (LDEX-CAFST8SIA2) to determine if we can rescue the
A549 tumor cell invasive phenotype similar to what we showed using
HDEX-CAF (Figure 5G). LDEX-CAFST8SIA2 enhanced invasive
ability of A549 in 3D collagen matrix compared to control
LDEX-CAFGFP (Figure 5H and Supplementary Table S19, P =
.0152), indicating that ST8SIA2 expression is important in
promoting NSCLC invasion.
Clinical Impact of ST8SIA2 on NSCLC Prognosis
We explored the prognostic properties and clinical relevance of
ST8SIA2 by using NSCLC microarray gene expression datasets. We
analyzed the association of ST8SIA2 gene expression with the risk of
relapse in UHN clinical cohort (GSE50081). Our finding showed
that ST8SIA2 is significantly prognostic for rate of relapse using both
UHN cohort microarray data (Affymetrix) (P value = .033) and
RT-qPCR gene expression data (P value = .0027) in extreme
desmoplastic tumors in UHN cohort (Table 2). We further validated
ST8SIA2 as prognostic gene associated with the risk of relapse in two
additional independent NSCLC clinical datasets from DCC
(GSE68465) (P value = .00032) and Okayama (GSE31210) (P
value = .005) (Supplementary Tables S20 and S21).
Discussion
Desmoplastic tumor stroma is mainly characterized by abundance of
proliferating CAFs particularly at the boundaries between the invasive
cancer and the host tissue. Desmoplasia is associated with enhanced
tumor cell invasiveness and has been associated with tumor cell
malignancy [2325]. However, there are studies suggesting that
ablation of desmoplasia renders tumors more aggressive [16,17].
These conflicting effects of desmoplasia suggest that functions of
CAFs are not fully understood.
We have demonstrated that activated cancer stroma characterized
as high desmoplasia has prognostic significance in NSCLC patients.
Other groups have reached this statement in the past [26,27], but
their definition of desmoplasia was different, integrating more the
collagen aspect rather than fibroblast density as we did in this study.
Furthermore, we demonstrated that functional heterogeneity of
desmoplastic CAF is a determinant factor of NSCLC aggressiveness.
Here, we showed that compared to LD-NSCLC tumors, CAFs
resected from HD-NSCLC tumors demonstrated higher matrix
reorganizing ability and promotion of tumor cell invasion and
growth, confirming the existence of functional heterogeneity among
NSCLC CAFs. We profiled significant gene expression in primary
cultured CAFs after they remodeled the collagen matrix. We have
identified 13 differential CAF gene expressions that were significantly
correlated with desmoplasia. The top upregulated differentially
expressed gene between extreme desmoplastic HD-CAFs versus
LD-CAFs, ST8SIA2, increased invasion ability of A549 NSCLC
tumor cell line when overexpressed in LDEX-CAFs and increased
further the invasion ability of A549 tumor cells when overexpressed in
HDEX-CAFs. Most of all, ST8SIA2 was prognostic for rate of relapse
in UHN and two other independent clinical cohorts.
The mechanism contributing to the phenotypic and functional
heterogeneity among fibroblasts remains debated in lung cancer.
Only a few studies on the functional heterogeneity of CAFs in
different types of cancers have been reported. The effect of CAFs on
colon cancer cell migration ability identified a CAF gene expression
signature. This signature was able to classify colon cancer patients into
high- and low-risk groups [28]. Recently, a new functionally distinct
subset of CAFs was identified that was preferentially abundant in
breast chemoresistant tumors [29].
To date, the stroma influence on the tumor has mainly been
described as a prognostic marker in lung, colon, and breast cancer
[30,31]. Stroma-rich tumors in breast cancer patients were associated
with an increased risk of relapse [31]. Our analysis of the clinical
relevance of desmoplasia in a large cohort of 165 NSCLC patients
showed that desmoplasia is significantly associated with patient RR.
This posited the functional and clinical relevance of CAF
heterogeneity in NSCLC tumors.
To understand the biological role of desmoplasia in aggressiveness
of NSCLC tumors, we first characterized two CAFs subsets from 28
NSCLC patient tumors which were scored and classified based on
desmoplasia. Based on our RT-qPCR analysis using a prognostic
11-gene signature of CAFs from NSCLC patients [1], we could
differentiate between CAFs and their corresponding NFs; however,
we were unable to differentiate between HD-CAFs and LD-CAFs.
One explanation is that the 11CAF gene signature is based on in
vitro CAFs primary cultured cells comparing to their matched NFs
and is not related to the function of CAFs. Furthermore, we
investigated two CAF markersintegrin α11 and α-SMAthat are
expressed in CAF from NSCLC tumors. We observed a significant
correlation in mRNA expression and protein between α-SMA and
integrin α11 within CAFs and NFs, but no correlation between these
two markers within HD-CAFs and LD-CAFs, indicating that
desmoplasia is not a mere quantification of fibroblasts but is a
specific characteristic of activated stroma. Activation state of CAFs is a
major hallmark of marked tumor desmoplasia. Collagen gel
contraction reflects collagen matrix reorganization and is an in vitro
measurement of CAF activation. Harris et al. [32] have suggested that
traction forces at the surface of fibroblasts are the driving forces for
collagen remodeling and tissue morphogenesis. A model has been
proposed where the organization of the collagen meshwork explains
how traction forces might act in vivo to organize collagen fibers [33].
Our results showed that collagen gel contraction activity of CAFs is
correlated with desmoplasia. Collagen remodeling ability of CAFs is
considered an independent survival prognostic factor in many cancers
(2, 3). Our finding that CAF activity of collagen reorganization was
closely related to their tumor-promoting effect is consistent with a
previous study in CAFs from breast cancer [34]. In another study,
α-SMA staining and collagen contractibility of CAFs from colon
carcinoma suggested a link between the different activation level of
CAFs and their ability to enhance tumorigenicity [28]. It has been
speculated that CAFs share the same activation state, but their
expression of activation markers, such as α-SMA, FSP1, FAP, or
others, may differ [35]. Here, we present the first study that
demonstrates the correlation between desmoplasia and the heteroge-
neous activation state of CAFs.
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The functionality of CAFs has been demonstrated using in vivo
studies such as co-injection of CAFs together with tumor cells, which
enhances tumor growth by promoting ECM synthesis and stiffening,
inducing angiogenesis, and recruiting growth-promoting inflamma-
tory cells such as macrophages [2,7,3638]. Our data showed that
HD-CAFs promote NSCLC tumor growth compared to LD-CAFs.
Furthermore, in vitro data using Matrigel invasion assay and 3D
heterospheroid assay showed the enhanced invasive ability of tumor
cells co-cultured with HD-CAFs in comparison to those co-cultured
with LD-CAFs. These results suggest that HD-CAFs and LD-CAFs
are functionally heterogeneous with respect to their ability to promote
tumor growth and cancer cell invasion, respectively.
To characterize the phenotype of CAF activation, we profiled
significant gene expression in primary cultured CAFs during collagen
matrix remodeling. We have identified 13 significantly differentially
expressed genes in extreme cases of HD-CAFs versus extreme cases of
LD-CAFs. We showed that one of the top upregulated genes,
ST8SIA2, was prognostic for rate of relapse in extreme cases of UHN
clinical cohort and in two other independent clinical cohorts.
Moreover, overexpression of ST8SIA2 in HD-CAF and LD-CAF
increased A549 NSCLC tumor cell line dissemination in a 3D
collagen matrix heterospheroid culture, whereas ST8SIA2 knock-
down in HD-CAF decreased A549 tumor cell invasion. These results
indicated the crucial role of ST8SIA2 in tumor aggressiveness.
ST8SIA2 is a polysialyltransferase that synthesizes polysialic acid
(PSA) chains on different substrata, including the neural cell adhesion
molecule (NCAM), which once substituted with PSA has been shown
to increase tumor cell migration [39]. It is interesting to note that
PSA-NCAM can be shed and acts in its proximate environment [40].
It has also been reported that overexpression of ST8SIA2 can mediate
tumor cell invasiveness of hepatocellular carcinoma and small cell
lung cancer by regulating activity of the PI3K/Akt and FGFR
pathways, respectively [41,42]. In triple-negative breast cancer
models, Hedgehog ligand secreted by tumor cells activates CAFs,
leading to upregulation of ST8SIA2 expression [43]. Interestingly, in
the UHN dataset, we observed a correlation between ST8SIA2 and
Desert hedgehog ligand (DHH) gene expression (r = 0.504,
P value = 7.51e−6), suggesting that hedgehog signaling may in part
contribute to CAF activation in high desmoplastic NSCLC.
Conclusions
Our findings demonstrate that functional heterogeneity of desmo-
plastic CAF is a determinant factor of NSCLC aggressiveness; thus,
high desmoplastic CAFs represent a phenotypic subtype with a
functional role for ST8SIA2 in promoting NSCLC invasion.
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